DLL3 is one of the oncogenic drivers in SCLC, associated with neuroendocrine tumorigenesis, SCLC migration, and invasion through a mechanism that involves control of the epithelial–mesenchymal transition [42]. Here, DLL3 is linked to small cell lung carcinoma.